Ann: Imugene Granted India Patent for Oncolytic Virotherapy CF33, page-64

  1. 89 Posts.
    lightbulb Created with Sketch. 9
    Believe staying in constant touch with friends and family in India would help understanding the latest development there.

    Affordability is a concern, but it's not a deal-breaker. In many countries, including those with large low-income populations, cancer treatments are funded through government healthcare programs, insurance, NGOs, and tiered pricing models. In India, for example, schemes like Ayushman Bharat cover treatment costs for millions of low-income patients. Believe the World Bank estimates that while around 10% of India’s population earns below $2.15/day, that still leaves over 1.25 billion people with higher earnings, many of whom can afford treatment through various funding mechanisms. The market potential remains enormous.

    On top of it, someone well connected in India would know the fact in today's scenario of India - Wages are quite high, spending on health is enormous there. Not everything is green there, but a true picture is not something a vague statement of low financial status and spreading confusion.

    Coming back to the track of IMU - Overall its a big achievement for IMU to get China and India on the list.
    Last edited by rsytsydney1: 27/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
0.001(7.69%)
Mkt cap ! $104.5M
Open High Low Value Volume
1.2¢ 1.4¢ 1.2¢ $267.3K 20.57M

Buyers (Bids)

No. Vol. Price($)
5 788815 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 13241534 29
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.